Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil
Evidence on effectiveness, safety, and tolerability of imipenem/clavulanate (IC) and linezolid containing regimens to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) is scarce. The aim of this observational study is to evaluate the therapeutic contribution of IC...
Main Authors: | M.A. Arbex, E.H. Bonini, G. Kawakame Pirolla, L. DâAmbrosio, R. Centis, G.B. Migliori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-11-01
|
Series: | Revista Portuguesa de Pneumologia (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173511516300707 |
Similar Items
-
Multidrug-resistant tuberculosis today
by: A Matteelli, et al. -
Multidrug-resistant tuberculosis today
by: A Matteelli, et al.
Published: (2012-02-01) -
Treatment of Ventilator-Associated Gram-Negative Pneumonia with Imipenem-Cilastatin/Amikacin Versus Ticarcillin-Clavulanate/Amikacin
by: Ahmet ELALDI, et al.
Published: (2006-06-01) -
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
by: Amaylia Oehadian, et al.
Published: (2022-04-01) -
Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
by: Yuan Yuan, et al.
Published: (2022-09-01)